Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders
Authors:
- 1 June 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 148 (1) , 33-41
Abstract
The importance of distinguishing mature B-cell lymphoproliferative disorders (B-LPDs) is highlighted by the distinct treatments used for and varying prognoses seen in association with these different diseases. Immunophenotyping allows for accurate and efficient differentiation of many B-LPDs. Recently, we showed that CD200 is highly expressed in hairy cell leukemia (HCL) but not in marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), or hairy cell leukemia-variant (HCL-v). Here, we assessed the usefulness of a flow cytometric panel combining CD200 and CD1d with CD25, CD103, and CD11c to distinguish CD10–, CD5– B-LPDs. We analyzed the expression of CD200 and CD1d by flow cytometric analysis in 79 cases of CD10–, CD5– mature B-LPDs. Distinct patterns of CD200 and CD1d expression were seen in the examined B-LPDs. HCL showed bright positivity for CD200 along with positive staining for CD1d, whereas HCL-v showed low levels of expression for both markers. LPL demonstrated positive staining for CD200 in combination with dim to negative staining for CD1d. In contrast, MZL was commonly positive for CD1d and negative for CD200. Flow cytometric analysis of CD200 and CD1d, along with CD25, CD103, and CD11c, can aid in the diagnosis of CD10–, CD5– mature B-LPDs.Keywords
This publication has 33 references indexed in Scilit:
- The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone developmentJournal of Experimental Medicine, 2012
- Expression of CD200 on AML blasts directly suppresses memory T-cell functionLeukemia, 2012
- Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell MyelomaAmerican Journal of Clinical Pathology, 2012
- BRAFMutations in Hairy-Cell LeukemiaNew England Journal of Medicine, 2011
- CD1d and CD1c Expression in Human B Cells Is Regulated by Activation and Retinoic Acid Receptor SignalingThe Journal of Immunology, 2011
- CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemiaLeukemia, 2011
- CD200 (OX-2 Membrane Glycoprotein) Expression in B Cell–Derived NeoplasmsAmerican Journal of Clinical Pathology, 2010
- CD200/OX2, a cell surface molecule with immuno‐regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cellsBritish Journal of Haematology, 2009
- CD200 as a prognostic factor in acute myeloid leukaemiaLeukemia, 2007
- THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and GlycolipidsAnnual Review of Immunology, 1999